Multisystem Inflammatory Syndrome
- 20 September 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiology in Review
- Vol. 31 (2) , 61-64
Abstract
The novel coronavirus (severe acute respiratory syndrome coronavirus-2), also referred to as coronavirus disease 2019, has caused a global pandemic that cost more than 900,000 deaths and affected nearly 80 million Americans since the start of the pandemic in early 2020. A majority of cases have primarily been reported in the adult population. Initially, lower morbidity and mortality rates were noted in children, compared with adults. However, some pediatric patients have been shown to develop a rare, but severe complication of severe acute respiratory syndrome coronavirus-2 infection, referred to as Multisystem Inflammatory Syndrome in Children. The condition has now been reported in adults as well. In this article, the origins, clinical features, pathogenesis, treatment, and latest literature on multisystem inflammatory syndrome are explored.Keywords
This publication has 24 references indexed in Scilit:
- Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care UnitsChest, 2021
- The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19Cell, 2020
- Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approachEuropean Journal of Pediatrics, 2020
- Multisystem Inflammatory Syndrome in Children in New York StateNew England Journal of Medicine, 2020
- Multisystem Inflammatory Syndrome in U.S. Children and AdolescentsNew England Journal of Medicine, 2020
- Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2JAMA, 2020
- Viral and host factors related to the clinical outcome of COVID-19Nature, 2020
- Hyperinflammatory shock in children during COVID-19 pandemicThe Lancet, 2020
- IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditisClinical and Experimental Immunology, 2019
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseasesBlood, 2011